Status: current, Primitive. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3243491000168113 | Ogivri (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3243501000168118 | Ogivri | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ogivri | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ogivri 150 mg powder for injection, 150 mg vial | Is a | True | Ogivri | Inferred relationship | Some | |
| Ogivri 150 mg powder for injection, 1 vial | has TP | True | Ogivri | Inferred relationship | Some | |
| Ogivri (trastuzumab 150 mg) powder for injection, 1 x 150 mg vial (containered trade product pack) | has TP | True | Ogivri | Inferred relationship | Some | |
| Ogivri (1 x 440 mg vial, 1 x 20 mL inert diluent vial), 1 pack | has TP | True | Ogivri | Inferred relationship | Some | |
| Ogivri (1 x 440 mg vial, 1 x 20 mL inert diluent vial), 1 pack | has TP | True | Ogivri | Inferred relationship | Some | |
| Ogivri (inert substance) diluent, 20 mL vial | Is a | True | Ogivri | Inferred relationship | Some | |
| Ogivri (trastuzumab 440 mg) powder for injection, 440 mg vial | Is a | True | Ogivri | Inferred relationship | Some |
Reference Sets
FHIR